Latanoprost/Timolol Eg (Latanoprost, Timolol)

Latanoprost, a prostaglandin analog, binds to FP receptors in the ciliary body, enhancing uveoscleral outflow of aqueous humor. This increased drainage lowers intra‑ocular pressure, complementing timolol’s reduction of fluid production.

The prescribed dose is determined by the treating ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily, but the exact regimen should follow the clinician’s instructions and the product label.

Safety data in pregnancy and lactation are limited. The medication should be used only if the potential benefit justifies the potential risk to the fetus or infant. Physicians should discuss individual circumstances with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with monotherapy agents, the combination offers dual mechanisms—enhanced outflow via latanoprost and reduced production via timolol—often achieving greater pressure reduction with a single drop. This can improve adherence versus using two separate eye drops.

Store the ophthalmic solution below 25 °C in its original container, protecting it from light and moisture. Do not freeze. Keep the bottle tightly closed when not in use and discard any solution that appears discolored or contaminated.

The medication is administered as an eye drop. The patient should wash hands, tilt the head back, pull down the lower eyelid to form a pocket, and place one drop into the conjunctival sac. Close the eye gently and avoid blinking excessively for a few seconds.

Serious risks include severe allergic reactions, sudden vision loss, and systemic beta‑blocker effects such as bradycardia, hypotension, or bronchospasm, especially in patients with underlying cardiac or respiratory disease. Prompt medical attention is required if these occur.

Patients with known hypersensitivity to latanoprost, timolol, or any excipients should avoid the product. It is also contraindicated in individuals with severe asthma, chronic obstructive pulmonary disease, bradycardia, or heart block unless closely monitored by a physician.